Crystal Adam sold TNGX
April 15, 2026 · Form 4 insider transaction
Crystal Adam sold 38,460 shares of Tango Therapeutics, Inc. at $25.00 per share, a transaction worth $961.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
38,460
Price
$25.00
Total value
$961.5K
InsiderCrystal Adam
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 15, 2026
Filing dateApril 16, 2026
Shares owned after112,622
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 27, 2025.